Safety Study of Denosumab in Subjects With Recurrent or Unresectable Giant Cell Tumor of Bone

Sponsors and Collaborators
Amgen

Contact
Amgen Call Center
866-572-6436


Continue Reading

Investigator
Amgen

ClinicalTrials.gov Identifier
NCT00680992